Appearance of angiotensin II expression in non-basal epithelial cells is an early feature of malignant change in human prostate

Cancer Detection and Prevention - Tập 31 - Trang 391-395 - 2007
Simon N. Louis1, Lin Wang1, Laurie Chow1, Linda A. Rezmann1, Keisaku Imamura1, Duncan P. MacGregor2, David Casely3, Kevin J. Catt4, Albert G. Frauman1, William J. Louis1
1Clinical Pharmacology and Therapeutics Unit, University of Melbourne, Department of Medicine, Austin Health, Heidelberg, 3084 Vic., Australia
2Department of Anatomical Pathology, Austin Health, Heidelberg, 3084 Vic., Australia
3Department of Medicine, University of Melbourne, Austin Health, Heidelberg, 3084 Vic., Australia
4Endocrinology and Reproduction Research Branch, NICHD, National Institutes of Health, Bethesda, MD 20892-4510, USA.

Tài liệu tham khảo

de Gasparo, 2000, International union of pharmacology. XXIII. The angiotensin II receptors, Pharmacol Rev, 52, 415 Abali, 2002, Old antihypertensives as novel antineoplastics: angiotensin-I-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists, Med Hypotheses, 59, 344, 10.1016/S0306-9877(02)00185-8 Lever, 1998, Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer?, Lancet, 352, 179, 10.1016/S0140-6736(98)03228-0 Dinh, 2002, Evidence for activation of the renin-angiotensin system in the human prostate: increased angiotensin II and reduced AT(1) receptor expression in benign prostatic hyperplasia, J Pathol, 196, 213, 10.1002/path.1021 Uemura, 2005, Antiproliferative activity of angiotensin II receptor blocker through cross-talk between stromal and epithelial prostate cancer cells, Mol Cancer Ther, 4, 1699, 10.1158/1535-7163.MCT-04-0295 Lijovic, 2002, KAI1/CD82 protein expression in primary prostate cancer and in BPH associated with cancer, Cancer Detect Prev, 26, 69, 10.1016/S0361-090X(02)00012-0 Johnston, 1971, Evaluation of renin and angiotensin assays and their clinical application, Med J Aust, 1, 126, 10.5694/j.1326-5377.1971.tb87472.x Gleason, 1966, Classification of prostatic carcinomas, Cancer Chemother Rep, 50, 125 Tamimi, 1993, Increased expression of high mobility group protein I(Y) in high grade prostatic cancer determined by in situ hybridization, Cancer Res, 53, 5512 Takahashi, 2006, Differences between latent and clinical prostate carcinomas: lower cell proliferation activity in latent cases, Prostate, 66, 211, 10.1002/pros.20336 Petein, 1996, Does any correlation exist between the Gleason classification system and the computer-assisted microscope analysis of Feulgen-stained nuclei features in human prostate adenocarcinoma?, Anal Cell Pathol, 12, 159 Kristiansen, 2003, ALCAM/CD166 is up-regulated in low-grade prostate cancer and progressively lost in high-grade lesions, Prostate, 54, 34, 10.1002/pros.10161 Horoszewicz, 1980, The LNCaP cell line--a new model for studies on human prostatic carcinoma, Prog Clin Biol Res, 37, 115 Stone, 1978, Isolation of a human prostate carcinoma cell line (DU 145), Int J Cancer, 21, 274, 10.1002/ijc.2910210305 Kaighn, 1979, Establishment and characterization of a human prostatic carcinoma cell line (PC-3), Invest Urol, 17, 16 Young RH, Srigley JR, Amin MB, Ulbright TM, Cubilla AL. Tumors of the prostate gland, seminal vesicles, male urethra, and penis (Atlas of tumor pathology, 3rd series, f. 28). Washington, DC: Armed Forces Institute of Pathology; 2000. Uemura, 2003, Angiotensin II receptor blocker shows antiproliferative activity in prostate cancer cells: a possibility of tyrosine kinase inhibitor of growth factor, Mol Cancer Ther, 2, 1139 Bonkhoff, 1994, The proliferative function of basal cells in the normal and hyperplastic human prostate, Prostate, 24, 114, 10.1002/pros.2990240303 Bonkhoff, 1996, Role of the basal cells in premalignant changes of the human prostate: a stem cell concept for the development of prostate cancer, Eur Urol, 30, 201, 10.1159/000474170 Reiter, 1998, Prostate stem cell antigen: a cell surface marker overexpressed in prostate cancer, Proc Natl Acad Sci USA, 95, 1735, 10.1073/pnas.95.4.1735 Schalken, 2003, Cellular and molecular biology of the prostate: stem cell biology, Urology, 62, 11, 10.1016/S0090-4295(03)00758-1 Verhagen, 1992, Colocalization of basal and luminal cell-type cytokeratins in human prostate cancer, Cancer Res, 52, 6182 Bostwick, 2004, High-grade prostatic intraepithelial neoplasia, Mod Pathol, 17, 360, 10.1038/modpathol.3800053 Cheng, 2004, Prostatic intraepithelial neoplasia: an update, Clin Prostate Cancer, 3, 26, 10.3816/CGC.2004.n.009 Dinh, 2001, Identification, distribution, and expression of angiotensin II receptors in the normal human prostate and benign prostatic hyperplasia, Endocrinology, 142, 1349, 10.1210/en.142.3.1349 Singh, 2007, High glucose induced regulation of intracellular angiotensin ii synthesis and nuclear redistribution in cardiac myocytes, Am J Physiol Heart Circ Physiol, 10.1152/ajpheart.00391.2007